RGT-018

News alerts, weekly reports and conference planners

Company:

Regor

Drug class:

SOS1 inhibitor

Related drugs:

‹

›

KRAS mutation	Lung Cancer	KRAS mutation	Lung Cancer	RGT-018 Sensitive: D – Preclinical RGT-018 Sensitive : D	RGT-018 Sensitive: D – Preclinical RGT-018 Sensitive : D
KRAS mutation	Pancreatic Cancer	KRAS mutation	Pancreatic Cancer	RGT-018 Sensitive: D – Preclinical RGT-018 Sensitive : D	RGT-018 Sensitive: D – Preclinical RGT-018 Sensitive : D

Associations
(2)